AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Processa Pharmaceuticals, Inc. Director's Dealing 2025

Sep 18, 2025

35172_dirs_2025-09-18_d4762196-c9b0-4b42-9efe-7fbcbb78528f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-07-24

Reporting Person: SKIBSTED RUSSELL (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$0		Common Stock (28000)	28000	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of 50% on 7/16/25 and the remainder upon achievement of certain criteria.